Specific serum microRNA profile in the molecular diagnosis of Hirschsprung's disease

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 8, 2014, Pages 1580-1587

  Tang, Weibing ^a,b   Li, Hongxing ^a,b   Tang, Junwei ^a,b   Wu, Wei ^a   Qin, Jingjing ^a,c   Lei, Hao ^a,b   Cai, Peng ^a,b   Huo, Weiwei ^a   Li, Bo ^a,b   Rehan, Virender ^d   Xu, Xiaoqun ^a,b   Geng, Qiming ^b   Zhang, Hongwei ^c   Xia, Yankai ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c XUZHOU MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diagnosis; HSCR; Serum miRNA; Signature

Indexed keywords

MESSENGER RNA; MICRORNA; TUMOR MARKER;

BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HIRSCHSPRUNG DISEASE; HUMAN; INFANT; MALE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; DOUBLE-BLIND METHOD; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HIRSCHSPRUNG DISEASE; HUMANS; INFANT; MALE; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84912573138     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12348     Document Type: Article

References (31)

1. Amiel J, Sproat-Emison E, Garcia-Barcelo M, et al. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 2008; 45: 1-14.
2. Emison ES, McCallion AS, Kashuk CS, et al. A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk. Nature. 2005; 434: 857-63.
3. Haricharan RN, Georgeson KE. Hirschsprung disease. Semin Pediatr Surg. 2008; 17: 266-75.
4. Coran AG, Teitelbaum DH. Recent advances in the management of Hirschsprung's disease. Am J Surg. 2000; 180: 382-7.
5. Lewis NA, Levitt MA, Zallen GS, et al. Diagnosing Hirschsprung's disease: increasing the odds of a positive rectal biopsy result. J Pediatr Surg. 2003; 38: 412-6.
6. Diamond IR, Casadiego G, Traubici J, et al. The contrast enema for Hirschsprung disease: predictors of a false-positive result. J Pediatr Surg. 2007; 42: 792-5.
7. Osatakul S, Patrapinyokul S, Osatakul N. The diagnostic value of anorectal manometry as a screening test for Hirschsprung's disease. J Med Assoc Thai. 1999; 82: 1100.
8. Menezes M, Puri P. Long-term outcome of patients with enterocolitis complicating Hirschsprung's disease. Pediatr Surg Int. 2006; 22: 316-8.
9. Hosako H, Martin GS, Barrier M, et al. Gene and microRNA expression in p53-deficient day 8.5 mouse embryos. Birth Defects Res A Clin Mol Teratol. 2009; 85: 546-55.
10. Kroh EM, Parkin RK, Mitchell PS, et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods. 2010; 50: 298-301.
11. Liu R, Chen X, Du Y, et al. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem. 2012; 58: 610-8.
12. Wu W, Qin Y, Li Z, et al. Genome-wide microRNA expression profiling in idiopathic non-obstructive azoospermia: significant upregulation of miR-141, miR-429 and miR-7- 1-3p. Hum Reprod. 2013; 28: 1827-36.
13. Zhao C, Dong J, Jiang T, et al. Early second- trimester serum miRNA profiling predicts gestational diabetes mellitus. PLoS ONE. 2011; 6: e23925.
14. Luo Y, Wang C, Chen X, et al. Increased serum and urinary microRNAs in children with Idiopathic Nephrotic syndrome. Clin Chem. 2013; 59: 658-66.
15. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008; 18: 997-1006.
16. Giráldez MD, Lozano JJ, Ramírez G, et al. Circulating MicroRNAs as biomarkers of colorectal cancer: results from a genomewide profiling and validation study. Clin Gastroenterol Hepato. 2013; 11: 681-8.e3.
17. Eichelser C, Flesch-Janys D, Chang-Claude J, et al. Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression. Clin Chem. 2013; 59: 1489-96.
18. Liu R, Chen X, Du Y, et al. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem. 2011; 58: 610-8.
19. De Lorijn F, Kremer L, Reitsma J, et al. Diagnostic tests in Hirschsprung disease: a systematic review. J Pediatr Gastroenterol Nutr. 2006; 42: 496-505.
20. Jasonni V, Prato A. Hirschsprung's disease. Neonatology. San Francisco, CA: Springer; 2012. pp. 708-12.
21. Muller CO, Mignot C, Belarbi N, et al. Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Pediatr Surg Int. 2012; 28: 597-601.
22. Holschneider AM, Puri P. Hirschsprung's disease and allied disorders. Shanghai, China: Springer; 2000.
23. Santos MM, Tannuri U, Coelho MCM. Study of acetylcholinesterase activity in rectal suction biopsy for diagnosis of intestinal dysganglionoses: 17-year experience of a single center. Pediatr Surg Int. 2008; 24: 715-9.
24. Hall NJ, Kufeji D, Keshtgar A. Out with the old and in with the new: a comparison of rectal suction biopsies with traditional and modern biopsy forceps. J Pediatr Surg. 2009; 44: 395-8.
25. Cortez MA, Calin GA. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther. 2009; 9: 703-11.
26. Candiani S, Moronti L, Tonelli DDP, et al. A study of neural-related microRNAs in the developing amphioxus. Evodevo. 2011; 2: 1-18.
27. Sempere LF, Freemantle S, Pitha-Rowe I, et al. Expression profiling of mammalian microRNAs uncovers a subset of brainexpressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004; 5: R13.
28. McKeown SJ, Stamp L, Hao MM, et al. Hirschsprung Disease: a developmental disorder of the enteric nervous system. Wiley Interdiscip Rev Dev Biol. 2013; 2: 113-29.
29. Díaz-Beyá M, Navarro A, Ferrer G, et al. Acute myeloid leukemia with translocation (8; 16)(p11; p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene. Leukemia. 2012; 27: 595-603.
30. Song L, Huang Q, Chen K, et al. miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-β. Biochem Biophys Res Commun. 2010; 402: 135-40.
31. Brase JC, Johannes M, Schlomm T, et al. Circulating miRNAs are correlated with tumor progression in prostate cancer. Int J Cancer. 2011; 128: 608-16.